Coherus BioSciences Inc (CHRS)
1.45
-0.06
(-3.97%)
USD |
NASDAQ |
Jan 10, 12:14
Coherus BioSciences Enterprise Value: 340.79M for Jan. 8, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Amgen Inc | 193.41B |
| Eli Lilly and Co | 775.00B |
| CEL-SCI Corp | 22.99M |
| AIM ImmunoTech Inc | 9.354M |
| IGC Pharma Inc | 24.25M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.75M |
| Revenue (Quarterly) | 70.77M |
| Total Expenses (Quarterly) | 77.16M |
| EPS Diluted (Quarterly) | -0.09 |
| Gross Profit Margin (Quarterly) | 70.69% |
| Profit Margin (Quarterly) | -15.19% |
| Earnings Yield | -5.52% |
| Normalized Earnings Yield | -96.16 |